Xeptiva Therapeutics
About:
Xeptiva is a biotechnology company developing therapies for the treatment of chronic inflammation in companion animals
Website: https://www.xeptiva.com/
Twitter/X: xeptiva
Top Investors: NDLATAM, Uruguay Biotech Ventures, Fen Ventures, iThink VC, Zentynel Frontier Investments
Description:
Xeptiva Therapeutics is a veterinary biotechnology company that focuses on developing therapies for chronic inflammation conditions in companion animals. Its main products target chronic pain associated with osteoarthritis and atopic dermatitis in dogs. In addition, the company is developing therapies for the treatment of pain in horses and asthma in cats. Xeptiva's goal is to allow pets to live longer and healthier by targeting the underlying source of many chronic diseases.
$3.15M
Montevideo, NA - Uruguay, Uruguay
2021-01-01
info(AT)xeptiva.com
Emiliano Trias, Josefina Correa, Luis Barbeito
1-10
2024-09-23
Private
© 2025 bioDAO.ai